Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

MP4, a new nonvasoactive PEG-Hb conjugate.

Kim D Vandegriff1, Ashok Malavalli, Jerod Wooldridge

  • 1Sangart, Inc., 11189 Sorrento Valley Road, Suite 104, San Diego, CA 92121, USA.

Transfusion
|March 29, 2003
PubMed
Summary

Surface-modified hemoglobin (MP4) was developed to overcome vasoconstriction in red blood cell substitutes. This novel hemoglobin carrier shows no pressor effect, addressing a key limitation in developing safe oxygen carriers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

LOW-VOLUME RESUSCITATION WITH VS -101, A NEXT-GENERATION PEGYLATED HEMOGLOBIN-BASED OXYGEN CARRIER, IMPROVES SURVIVAL AFTER SEVERE HEMORRHAGIC SHOCK IN RATS.

Shock (Augusta, Ga.)·2025
Same author

EXCHANGE TRANSFUSION WITH VS -101: A NEW PEGYLATED-HB DESIGNED TO RESTORE PERFUSION AND INCREASE O 2 CARRYING CAPACITY.

Shock (Augusta, Ga.)·2023
Same author

How Nitric Oxide Hindered the Search for Hemoglobin-Based Oxygen Carriers as Human Blood Substitutes.

International journal of molecular sciences·2023
Same author

Systemic and microvascular comparison of Lactated Ringer's solution, VIR-HBOC, and alpha-alpha crosslinked haemoglobin-based oxygen carrier in a rat 10% topload model.

Artificial cells, nanomedicine, and biotechnology·2020
Same author

Blood Substitutes.

Surgical technology international·2017
Same author

Ventilation and the control of erythropoiesis in high-altitude natives of Chile and Nepal.

American journal of human biology : the official journal of the Human Biology Council·2017

Area of Science:

  • Biochemistry
  • Biomaterials Science
  • Pharmacology

Background:

  • Vasoconstriction is a significant hurdle in the clinical application of hemoglobin-based oxygen carriers (HBOCs).
  • Increasing molecular size and oxygen affinity of HBOCs may mitigate this limitation.

Purpose of the Study:

  • To design and characterize a surface-modified hemoglobin (MP4) to overcome the pressor effect associated with HBOCs.
  • To evaluate the physicochemical and physiological properties of MP4 as a potential red blood cell substitute.

Main Methods:

  • Human hemoglobin was chemically modified with 2-iminothiolane and polyethylene glycol (PEG) to create MP4.
  • MP4's molecular weight, radius, oxygen affinity, Bohr effect, viscosity, and oncotic pressure were measured.
  • The in vivo pressor effect and circulation time of MP4 in rats were assessed.

Related Experiment Videos

Main Results:

  • MP4 exhibited a molecular weight of 90 kDa and an increased molecular radius (9.3 nm) compared to native hemoglobin.
  • MP4 demonstrated high oxygen affinity (p50 ~5-6 mmHg) and a reduced Bohr effect.
  • No significant elevation in mean arterial pressure was observed in rats, and the circulation half-life (t50) was approximately 24 hours.

Conclusions:

  • MP4, a surface-modified hemoglobin, shows promise as a red blood cell substitute.
  • MP4 appears to be free of the pressor effect, a critical safety concern for HBOC development.